A paper at the National Bureau of Economic Research examines why clinical guidelines often seem to have little relevance or utility.
A study in Health Affairs examines characteristics of persistent high ER use patients.
We continue with our summary of the Kaiser Family Foundation survey on 2017 employer health plans.
Today and tomorrow we will present some highlights from the annual Kaiser survey of employer-sponsored health plans.
An analysis in Health Affairs finds that low-cost, but high-volume services are the single largest contributor to unnecessary health spending.
MedPAC’s updated report on geographical variation in Medicare spending finds some lessening of differences.
MDVIP issues survey results regarding how doctors feel about their work environment.
A Deloitte report focuses on how drug companies can get more connected with patients using their products.
Two briefs from the Peterson-Kaiser Health System Tracker look at out-of-pocket spending trends.
A Magellan report shows that specialty drug costs are a big issue for Medicaid too.
Research published in Health Affairs finds that high-deductible plans discourage both needed and unnecessary care use.
A Segal analysis of medical cost trends for 2018 suggests that drug spending is still the major problem.
A report from Xcenda performs a site of care analysis for cancer treatment.
JP Morgan Chase issues a fact-filled report on consumer out-of-pocket spending on health care.
The Commonwealth Fund releases a brief describing certain employers’ effort to manage high-cost patients.